Coastal Infusion Administers Renflexis^®

Renflexis (infliximab-abda) is used to treat certain types of arthritis.

In inflammatory conditions, the immune system becomes excessively active, generating an abundance of TNF-alpha (tumor necrosis factor alpha) protein. This prompts the immune system to target and attack healthy cells. Renflexis hinders this by inhibiting TNF-alpha, a key cytokine in the inflammatory response.

By modulating the hyperactive immune response, Renflexis effectively alleviates symptoms such as joint pain, swelling, and restricted mobility.

What It Treats

• Crohn's disease
• Ulcerative colitis (UC)
• Rheumatoid arthritis (RA)
• Psoriatic arthritis
• Plaque psoriasis
• Ankylosing spondylitis

Prescribed By

Renflexis is most often prescribed by Gastroenterologists, Rheumatologists, and Dermatologists.

How it's Administered

Renflexis is administered by intravenous infusion. Renflexis infusions take about two hours.

Frequency

Renflexis is administered every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks.

Related Drugs

Avsola, Inflectra, Remicade

Additional Resources

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies